Cargando…
OR03-4 Atypical Femur Fracture Incidence Increases with Duration of Bisphosphonate Exposure
BACKGROUND: Dell et al. reported that the incidence of atypical femur fracture (AFF) increased with duration of bisphosphonate (BP) exposure, ranging from 2 to 113 per 100,000 person-years with <2 to 8-10 years (yrs) treatment, respectively (JBMR 27:2544, 2012). These estimates were based on 128...
Autores principales: | Lo, Joan, Grimsrud, Christopher, Ott, Susan, Chandra, Malini, Hui, Rita, Sanchez, Gabriela, Gonzalez, Joel, Ettinger, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554828/ http://dx.doi.org/10.1210/js.2019-OR03-4 |
Ejemplares similares
-
MON-510 Progression of Atypical Femur Stress Fracture after Discontinuation of Bisphosphonate Therapy
por: Gu, Kristine, et al.
Publicado: (2019) -
SAT-534 How Has Bisphosphonate Prescribing Changed in the Past Decade for Primary Fracture?
por: Yang, Betsy, et al.
Publicado: (2019) -
SAT-531 Low 25-OH-Vitamin D Levels in Women Observed before Initiating Osteoporosis Therapy
por: Li, Christina, et al.
Publicado: (2019) -
OR01-1 Proximal Femur Fracture Incidence by Sex among Older US Asian/Pacific Islander Adults and non-Hispanic White Adults
por: Chandra, Malini, et al.
Publicado: (2022) -
SAT-524 Re-hospitalization And Mortality Outcome Following Atypical Femur Fracture
por: Yang, Betsy, et al.
Publicado: (2019)